Paul Ian Tartter
Overview
Explore the profile of Paul Ian Tartter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zambetti A, Tartter P
Breast J
. 2013 Feb;
19(2):168-72.
PMID: 23406171
Numerous studies have convincingly shown that women with low bone mineral density have lower risk of breast cancer. As many risk factors for breast cancer are also prognostic factors, we...
2.
Malik M, Tartter P, Belfer R
J Cancer Epidemiol
. 2013 Feb;
2013:893104.
PMID: 23365573
The effect of undertreatment with adjuvant hormonal therapy, chemotherapy, or radiation was studied in elderly women with breast cancer. A prospectively maintained database was used to identify women undergoing potentially...
3.
Thu Ma A, Barone J, Wallis A, Wu N, Garcia L, Estabrook A, et al.
Am J Surg
. 2008 Sep;
196(4):500-4.
PMID: 18809051
Introduction: There is little information on patient-driven noncompliance of adjuvant therapies and its consequences. Methods: This retrospective study compares clinical, pathological features and outcomes of breast cancer patients who were...
4.
Greene T, Tartter P, Smith S, Estabrook A
Am J Surg
. 2006 Sep;
192(4):499-501.
PMID: 16978959
Background: The significance of surgical margins for patients with atypical ductal hyperplasia is unknown. Patients And Methods: We reviewed our experience with atypical ductal hyperplasia and correlated the margin status...
5.
Menes T, Tartter P, Bleiweiss I, Godbold J, Estabrook A, Smith S
Ann Surg Oncol
. 2005 Oct;
12(11):881-5.
PMID: 16195834
Background: Microscopically clear lumpectomy margins are critical for optimizing local control with breast conservation for cancer. Re-excisions are often necessary to achieve clear surgical margins. Factors that contribute to nonnegative...
6.
Menes T, Tartter P, Mizrachi H, Constantino J, Estabrook A, Smith S
J Am Coll Surg
. 2005 Mar;
200(3):323-7.
PMID: 15737841
Background: The recent American Joint Committee on Cancer revision of the staging system for breast cancer classifies sentinel node metastases < 0.2 mm (pN0[i+]) as node negative and those >...
7.
Menes T, Tartter P, Mizrachi H, Smith S, Estabrook A
Ann Surg Oncol
. 2003 Dec;
10(10):1166-70.
PMID: 14654472
Background: The preferred technique for intraoperative evaluation of the sentinel lymph node has not been determined. The purpose of this study was to compare the sensitivity and accuracy of intraoperative...
8.
Kaplan J, Giron G, Tartter P, Bleiweiss I, Estabrook A, Smith S
J Am Coll Surg
. 2003 Oct;
197(5):726-9.
PMID: 14585405
Background: Because breast cancer survival after breast conservation has proved comparable to mastectomy, contraindications to mastectomy are increasingly being challenged. We treated the majority of our patients with multiple synchronous...
9.
Dmytrasz K, Tartter P, Mizrachy H, Chinitz L, Smith S, Estabrook A
Breast J
. 2003 Feb;
9(1):10-2.
PMID: 12558664
Atypical lobular hyperplasia (ALH) is occasionally found in specimens obtained by percutaneous stereotactic vacuum-assisted breast biopsy for microcalcifications. Since malignancy is often found at surgical excision when atypical ductal hyperplasia...
10.
Tartter P, Gajdos C, Smith S, Estabrook A, Rademaker A
Am J Surg
. 2002 Jul;
184(1):11-5.
PMID: 12135711
Background: Because many risk factors for breast cancer are related to hormonal factors and hormonal factors influence breast cancer prognosis, risk factors may have prognostic value. In order to assess...